| Product Code: ETC7205066 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Finland saw a significant increase in import shipments of plasmid DNA manufacturing, with top exporting countries being the USA, Latvia, Metropolitan France, China, and Sweden. The market concentration, as measured by the HHI, remained at a moderate level, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 1.3%, showing steady expansion. Notably, the growth rate from 2023 to 2024 spiked at an impressive 74.32%, suggesting a rapid acceleration in demand for plasmid DNA manufacturing imports in Finland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Plasmid DNA Manufacturing Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Plasmid DNA Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Plasmid DNA Manufacturing Market - Industry Life Cycle |
3.4 Finland Plasmid DNA Manufacturing Market - Porter's Five Forces |
3.5 Finland Plasmid DNA Manufacturing Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.6 Finland Plasmid DNA Manufacturing Market Revenues & Volume Share, By Development Phase, 2021 & 2031F |
3.7 Finland Plasmid DNA Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Finland Plasmid DNA Manufacturing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 Finland Plasmid DNA Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for gene therapy and genetic engineering applications driving the need for plasmid DNA manufacturing. |
4.2.2 Technological advancements in biotechnology and gene editing techniques boosting the demand for plasmid DNA products. |
4.2.3 Government initiatives and funding supporting research and development activities in biotechnology and genetic engineering sectors in Finland. |
4.3 Market Restraints |
4.3.1 High costs associated with plasmid DNA manufacturing processes impacting profit margins. |
4.3.2 Stringent regulatory requirements and quality standards increasing compliance burdens on manufacturers. |
4.3.3 Limited availability of skilled workforce specialized in plasmid DNA manufacturing. |
5 Finland Plasmid DNA Manufacturing Market Trends |
6 Finland Plasmid DNA Manufacturing Market, By Types |
6.1 Finland Plasmid DNA Manufacturing Market, By Grade |
6.1.1 Overview and Analysis |
6.1.2 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Grade, 2021- 2031F |
6.1.3 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By R&D Grade, 2021- 2031F |
6.1.4 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By GMP Grade, 2021- 2031F |
6.2 Finland Plasmid DNA Manufacturing Market, By Development Phase |
6.2.1 Overview and Analysis |
6.2.2 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Pre-Clinical Therapeutics, 2021- 2031F |
6.2.3 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Clinical Therapeutics, 2021- 2031F |
6.2.4 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Marketed Therapeutics, 2021- 2031F |
6.3 Finland Plasmid DNA Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By DNA Vaccines, 2021- 2031F |
6.3.3 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.3.4 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3.5 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Finland Plasmid DNA Manufacturing Market, By Disease |
6.4.1 Overview and Analysis |
6.4.2 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.4.3 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.4.4 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.4.5 Finland Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Finland Plasmid DNA Manufacturing Market Import-Export Trade Statistics |
7.1 Finland Plasmid DNA Manufacturing Market Export to Major Countries |
7.2 Finland Plasmid DNA Manufacturing Market Imports from Major Countries |
8 Finland Plasmid DNA Manufacturing Market Key Performance Indicators |
8.1 Research and development investment in biotechnology sector. |
8.2 Number of patents filed for gene therapy and genetic engineering technologies. |
8.3 Adoption rate of plasmid DNA products in clinical trials and commercial applications. |
8.4 Average production yield and efficiency in plasmid DNA manufacturing processes. |
8.5 Level of collaboration and partnerships between academic institutions, research organizations, and biotech companies in advancing plasmid DNA technology. |
9 Finland Plasmid DNA Manufacturing Market - Opportunity Assessment |
9.1 Finland Plasmid DNA Manufacturing Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.2 Finland Plasmid DNA Manufacturing Market Opportunity Assessment, By Development Phase, 2021 & 2031F |
9.3 Finland Plasmid DNA Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Finland Plasmid DNA Manufacturing Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 Finland Plasmid DNA Manufacturing Market - Competitive Landscape |
10.1 Finland Plasmid DNA Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Finland Plasmid DNA Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |